Back
China Power International Development Ltd. 10K Form
Buy
56
CPWIF
China Power International Development Ltd.
Last Price:
$0.44
Seasonality Move:
1.33%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CPWIF News And Ratings
See the #1 stock for the next 7 days that we like better than CPWIF
CPWIF Financial Statistics
Sales & Book Value
| Annual Sales: | $7.5B |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.61 |
| Price / Book: | 0.72 |
Profitability
| EPS (TTM): | 0.03730 |
|---|---|
| Net Income (TTM): | $835.9M |
| Gross Margin: | $1.7B |
| Return on Equity: | 3.84% |
| Return on Assets: | 1.2% |
China Power International Development Ltd. Earnings Forecast
Key China Power International Development Ltd. Financial Ratios
-
The Gross Profit Margin over the past 22 years for CPWIF is 22.04%.
-
The Selling, General & Administrative Expenses for CPWIF have been equal to 1.85% of Gross Profit Margin.
-
The Research & Development expenses have been 0.65% of Revenue.
-
The Interest Expense is 81.68% of Operating Income.
-
The Net Earning history of CPWIF is 11.15% of Total Revenues.
-
Per Share Earnings over the last 22 years have been positive in 12 years.
China Power International Development Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Independent Power & Renewable Electricity Producer |
| Sector: | Utilities |
| Current Symbol: | CPWIF |
| Website: | chinapower.hk |
Debt
| Debt-to-Equity Ratio: | 3.5 |
|---|---|
| Current Ratio: | 0.55 |
| Quick Ratio: | 0.54 |
Price-to-Earnings
| Trailing P/E Ratio: | 11.53 |
|---|---|
| Forward P/E Ratio: | 0 |
CPWIF Technical Analysis vs Fundamental Analysis
Buy
56
China Power International Development Ltd. (CPWIF)
is a Buy
Is China Power International Development Ltd. a Buy or a Sell?
-
China Power International Development Ltd. stock is rated a BuyThe current China Power International Development Ltd. [CPWIF] share price is $0.44. The Score for CPWIF is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.